-
Weak evidence and lack of causality not mentioned in a headline that links milk consumption with an increased risk of prostate cancer
Medical Mythbusting Commentary for September 15, 2026 Source:Most men don’t know dairy is linked to prostate cancer risk Reference: A modest positive association between higher dairy/milk intake and prostate cancer risk is consistently observed in cohort studies, but the evidence is graded as “limited/suggestive” rather than causal, and the effect sizes are small. Pooled meta-analyses…
-
Regular consumption of hot beverages (> 149F/65C is associated with an increased risk of esophageal squamous cell carcinoma
Medical Mythbusting Commentary for September 11, 2026 Source:Hot Beverages May Triple Your Risk of Developing a Certain Type of Cancer Reference:Hot Drinks and Oesophageal Cancer: Prospective Analyses in Around 1 Million UK Adults The consumption of beverages at or above ~65°C (149°F) is linked to esophageal cancer, specifically esophageal squamous cell carcinoma (ESCC), and this…
-
Daily sugary drinks linked to 250 per cent higher stomach-cancer relative risk, but this translates into an absolute risk difference of 0.01 per cent because of the rarity of these cancers.
Medical Mythbusting Commentary for August 19, 2026 Source:Sugary drinks may increase risk of gastric cancer: study Reference:Association between sugar-sweetened and artificially sweetened beverage intake and gastric cancer incidence
-
An anti-cancer drug has been successfully repurposed to quiet a hyper-reactive immune system, giving hope to a kidney transplant who previously had none
Medical Mythbusting Commentary for July 31, 2026 Source:Medical breakthrough allows kidney transplant for patient with zero options Reference:T-Cell Engager–Mediated HLA Antibody Depletion before Kidney Transplantation.
-
Scientists decipher how T cells sense enemies—such as cancer—at point of contact
Medical Mythbusting Commentary for July 29, 2026 Source:Scientists decipher how T cells sense enemies—such as cancer—at point of contact Reference:PD-1 signaling and PD-1 blockade–mediated tumor control are established at microvillar T cell contacts
-
A new treatment for pancreatic cancer has been developed that on average increases survival from from six months to 12 but Canadians don’t have access to it. Here’s why.
Medical Mythbusting Commentary for July 15, 2026 Source:A new cancer treatment is hailed as a breakthrough, but Canadians don’t have access to it. Here’s why.
-
Genetic/molecular mechanism discovered to explain why heart muscle does not develop cancer or at least rarely does so.
Medical Mythbusting Commentary for June 29, 2026 Source:Why Does the Heart Rarely Develop Cancer?
-
Conflicting studies evaluating cancer risk after removal of the thymus.
Medical Mythbusting Commentary for June 18, 2026 Source:A ‘Useless’ Organ That Doctors Often Remove May Actually Fight Cancer Reference:The Thymus: Function and the Debate Over Its Removal The thymus is a small organ located behind the breastbone, in front of the heart. It serves as the “training ground” for T cells — the immune system’s soldiers that…
-
New medication for the treatment of advanced pancreatic cancer increases median overall survival from 6.7 to 13.2 months.
Medical Mythbusting Commentary for June 1, 2026 Source:‘I actually started crying’: Oncologist reacts to pancreatic cancer drug results Synopsis of the article and study: Benefits: Doubled survival, oral convenience, targeted action, manageable side effects. Limitations: Grade 3+ adverse events in about one-third of patients; still experimental, not yet fully approved; tested in advanced cases post-chemo.